241 related articles for article (PubMed ID: 20009155)
1. Atypical calcineurin inhibitor-induced haemolytic uremic syndrome after liver transplantation.
Furmańczyk A; Komuda-Leszek E; Durlik M
Ann Transplant; 2009; 14(4):47-51. PubMed ID: 20009155
[TBL] [Abstract][Full Text] [Related]
2. A case of late onset cyclosporine-induced hemolytic uremic syndrome resulting in renal graft loss.
Katafuchi R; Saito S; Ikeda K; Hirano T; Yanase T; Nakashima K; Fujimi S
Clin Transplant; 1999; 13 Suppl 1():54-8. PubMed ID: 10751058
[TBL] [Abstract][Full Text] [Related]
3. Posttransplantation calcineurin inhibitor-induced hemolytic uremic syndrome: single-center experience.
Said T; Al-Otaibi T; Al-Wahaib S; Francis I; Nair MP; Halim MA; El-Sayed A; Nampoory MR
Transplant Proc; 2010 Apr; 42(3):814-6. PubMed ID: 20430179
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus-associated hemolytic uremic syndrome: a case analysis.
Lin CC; King KL; Chao YW; Yang AH; Chang CF; Yang WC
J Nephrol; 2003; 16(4):580-5. PubMed ID: 14696762
[TBL] [Abstract][Full Text] [Related]
5. Severe rhabdomyolysis and acute renal failure secondary to concomitant use of simvastatin with rapamycin plus tacrolimus in liver transplant patient.
Dopazo C; Bilbao I; Lázaro JL; Sapisochin G; Caralt M; Blanco L; Castells L; Charco R
Transplant Proc; 2009 Apr; 41(3):1021-4. PubMed ID: 19376416
[TBL] [Abstract][Full Text] [Related]
6. [De novo hemolytic uremic syndrome in a kidney-pancreas recipient in the postoperative period].
Gutiérrez de la Fuente C; Sola E; Alférez MJ; Navarro A; Cabello M; Burgos D; González Molina M
Nefrologia; 2004; 24 Suppl 3():3-6. PubMed ID: 15219059
[TBL] [Abstract][Full Text] [Related]
7. Graft failure due to hemolytic uremic syndrome recurrence.
Iaria G; Iorio B; Anselmo A; De Luca L; Tariciotti L; Ielpo B; Muzi F; Lucchesi C; D'Andria D; Orlando G; Del Poeta G; Poggi E; Piazza A; Tisone G
Transplant Proc; 2006 May; 38(4):1020-1. PubMed ID: 16757250
[TBL] [Abstract][Full Text] [Related]
8. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus-induced hemolytic uremic syndrome and end-stage renal failure after liver transplantation.
Rerolle JP; Akposso K; Lerolle N; Mougenot B; Ponnelle T; Rondeau E; Sraer JD
Clin Transplant; 2000 Jun; 14(3):262-5. PubMed ID: 10831087
[TBL] [Abstract][Full Text] [Related]
10. Combination of everolimus with calcineurin inhibitor medication resulted in post-transplant haemolytic uraemic syndrome in lung transplant recipients--a case series.
Lovric S; Kielstein JT; Kayser D; Bröcker V; Becker JU; Hiss M; Schiffer M; Sommerwerck U; Haller H; Strüber M; Welte T; Gottlieb J
Nephrol Dial Transplant; 2011 Sep; 26(9):3032-8. PubMed ID: 21310739
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus-associated hemolytic uremic syndrome in a pediatric heart transplant recipient.
Gray JM; Ameduri RK
Pediatr Transplant; 2016 Sep; 20(6):866-7. PubMed ID: 27371345
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.
Yang YJ; Chen DZ; Li LX; Kou JT; Lang R; Jin ZK; Han DD; He Q
Transplant Proc; 2008 Jun; 40(5):1541-4. PubMed ID: 18589147
[TBL] [Abstract][Full Text] [Related]
14. A favorable 3-year outcome of kidney transplantation in atypical hemolytic uremic syndrome associated with a factor H mutation: case report.
Albertazzi V; Bonucchi D; De Amicis S; Americo C; Ghiandai G; Cappelli G
Transplant Proc; 2010 May; 42(4):1352-4. PubMed ID: 20534299
[TBL] [Abstract][Full Text] [Related]
15. Atypical relapse of hemolytic uremic syndrome after transplantation.
Olie KH; Florquin S; Groothoff JW; Verlaak R; Strain L; Goodship TH; Weening JJ; Davin JC
Pediatr Nephrol; 2004 Oct; 19(10):1173-6. PubMed ID: 15300478
[TBL] [Abstract][Full Text] [Related]
16. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
17. Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity.
Ziolkowski J; Paczek L; Senatorski G; Niewczas M; Oldakowska-Jedynak U; Wyzgal J; Sanko-Resmer J; Pilecki T; Zieniewicz K; Nyckowski P; Patkowski W; Krawczyk M
Transplant Proc; 2003 Sep; 35(6):2307-9. PubMed ID: 14529923
[TBL] [Abstract][Full Text] [Related]
18. Hot-topic debate on kidney function: renal-sparing approaches are beneficial.
Durand F
Liver Transpl; 2011 Nov; 17 Suppl 3():S43-9. PubMed ID: 21796759
[TBL] [Abstract][Full Text] [Related]
19. Hemolytic-uremic syndrome in association with both cyclosporine and tacrolimus.
Abraham KA; Little MA; Dorman AM; Walshe JJ
Transpl Int; 2000; 13(6):443-7. PubMed ID: 11140243
[TBL] [Abstract][Full Text] [Related]
20. A case of tacrolimus-associated thrombotic microangiopathy after ABO-blood-type-incompatible renal transplantation.
Takeda A; Ohtsuka Y; Horike K; Inaguma D; Goto N; Watarai Y; Uchida K; Morozumi K
Clin Transplant; 2011 Jul; 25 Suppl 23():15-8. PubMed ID: 21623908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
